Michael Halank
- Haemoptysis due to pulmonary venous stenosisBy Silke Braun, Ivan Platzek, Klaus Zöphel, Matthias Weise, Martin Kolditz, Michael Halank and Gert HoeffkenSilke Braun1Medical Clinic I, Dept of Pneumology, University Hospital Carl Gustav Carus, Dresden, Germany. 2Dept of Radiology, University Hospital Carl Gustav Carus, Dresden, Germany. 3Dept of Nuclear Medicine, University Hospital Carl Gustav Carus, Dresden, Germany. 4Medical Clinic III, ZIM - Cardiology, University Hospital Carl Gustav Carus, Dresden, Germany.Ivan Platzek1Medical Clinic I, Dept of Pneumology, University Hospital Carl Gustav Carus, Dresden, Germany. 2Dept of Radiology, University Hospital Carl Gustav Carus, Dresden, Germany. 3Dept of Nuclear Medicine, University Hospital Carl Gustav Carus, Dresden, Germany. 4Medical Clinic III, ZIM - Cardiology, University Hospital Carl Gustav Carus, Dresden, Germany.Klaus Zöphel1Medical Clinic I, Dept of Pneumology, University Hospital Carl Gustav Carus, Dresden, Germany. 2Dept of Radiology, University Hospital Carl Gustav Carus, Dresden, Germany. 3Dept of Nuclear Medicine, University Hospital Carl Gustav Carus, Dresden, Germany. 4Medical Clinic III, ZIM - Cardiology, University Hospital Carl Gustav Carus, Dresden, Germany.Matthias Weise1Medical Clinic I, Dept of Pneumology, University Hospital Carl Gustav Carus, Dresden, Germany. 2Dept of Radiology, University Hospital Carl Gustav Carus, Dresden, Germany. 3Dept of Nuclear Medicine, University Hospital Carl Gustav Carus, Dresden, Germany. 4Medical Clinic III, ZIM - Cardiology, University Hospital Carl Gustav Carus, Dresden, Germany.Martin Kolditz1Medical Clinic I, Dept of Pneumology, University Hospital Carl Gustav Carus, Dresden, Germany. 2Dept of Radiology, University Hospital Carl Gustav Carus, Dresden, Germany. 3Dept of Nuclear Medicine, University Hospital Carl Gustav Carus, Dresden, Germany. 4Medical Clinic III, ZIM - Cardiology, University Hospital Carl Gustav Carus, Dresden, Germany.Michael Halank1Medical Clinic I, Dept of Pneumology, University Hospital Carl Gustav Carus, Dresden, Germany. 2Dept of Radiology, University Hospital Carl Gustav Carus, Dresden, Germany. 3Dept of Nuclear Medicine, University Hospital Carl Gustav Carus, Dresden, Germany. 4Medical Clinic III, ZIM - Cardiology, University Hospital Carl Gustav Carus, Dresden, Germany.Gert Hoeffken1Medical Clinic I, Dept of Pneumology, University Hospital Carl Gustav Carus, Dresden, Germany. 2Dept of Radiology, University Hospital Carl Gustav Carus, Dresden, Germany. 3Dept of Nuclear Medicine, University Hospital Carl Gustav Carus, Dresden, Germany. 4Medical Clinic III, ZIM - Cardiology, University Hospital Carl Gustav Carus, Dresden, Germany.
- Safety and efficacy of exercise training in various forms of pulmonary hypertensionBy Ekkehard Grünig, Mona Lichtblau, Nicola Ehlken, Hossein A. Ghofrani, Frank Reichenberger, Gerd Staehler, Michael Halank, Christine Fischer, Hans-Jürgen Seyfarth, Hans Klose, Andreas Meyer, Stephan Sorichter, Heinrike Wilkens, Stephan Rosenkranz, Christian Opitz, Hanno Leuchte, Gabriele Karger, Rudolf Speich and Christian NagelEkkehard GrünigMona LichtblauNicola EhlkenHossein A. GhofraniFrank ReichenbergerGerd StaehlerMichael HalankChristine FischerHans-Jürgen SeyfarthHans KloseAndreas MeyerStephan SorichterHeinrike WilkensStephan RosenkranzChristian OpitzHanno LeuchteGabriele KargerRudolf Speich
- Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective surveyBy Stephanie Meyer, Vallerie V. McLaughlin, Hans-Juergen Seyfarth, Todd M. Bull, Carmine D. Vizza, Mardi Gomberg-Maitland, Ioana R. Preston, Joan A. Barberà, Paul M. Hassoun, Michael Halank, Xavier Jaïs, Nils Nickel, Marius M. Hoeper and Marc HumbertStephanie Meyer*Dept of Respiratory Medicine, Hannover Medical School, HannoverVallerie V. McLaughlin#Dept of Internal Medicine, Division of Cardiovascular Disease, University of Michigan Health System, Ann Arbor, MIHans-Juergen Seyfarth¶Dept of Respiratory Medicine, University of Leipzig, LeipzigTodd M. Bull+Dept of Medicine, Division of Pulmonary and Critical Care Medicine, Pulmonary Hypertension Center, University of Colorado Denver, Denver, COCarmine D. Vizza§Dept of Cardiovascular and Respiratory Science, University of Rome La Sapienza, Rome, ItalyMardi Gomberg-MaitlandfDept of Cardiology, University of Chicago, Chicago, ILIoana R. Preston**Dept of Pulmonary, Critical Care and Sleep, Tufts University School of Medicine, Boston, MAJoan A. Barberà##Dept of Pneumology, Hospital Clinic, CIBERES, University of Barcelona, Barcelona, SpainPaul M. Hassoun¶¶Dept of Medicine, Division of Pulmonary Critical Care Medicine, Johns Hopkins Medical University, Baltimore, MD, USAMichael Halank++Internal Medicine I, University of Dresden, Dresden, GermanyXavier Jaïs§§Université Paris-Sud, Assistance Publique Hôpitaux de Paris, INSERM UMR_S999 Le Kremlin-Bicêtre, FranceNils Nickel*Dept of Respiratory Medicine, Hannover Medical School, HannoverMarius M. Hoeper*Dept of Respiratory Medicine, Hannover Medical School, HannoverMarc Humbert§§Université Paris-Sud, Assistance Publique Hôpitaux de Paris, INSERM UMR_S999 Le Kremlin-Bicêtre, France
- Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trialBy Marius M. Hoeper, Michael Halank, Heinrike Wilkens, Andreas Günther, Gerrit Weimann, Irmingard Gebert, Hanno H. Leuchte and Jürgen BehrMarius M. Hoeper*Dept of Respiratory Medicine, Hannover Medical School, HannoverMichael Halank#Dept of Internal Medicine I, University Hospital Carl Gustav Carus, DresdenHeinrike Wilkens¶Dept of Internal Medicine II, University of the Saarland, HomburgAndreas Günther+Dept of Internal Medicine, Giessen University, GiessenGerrit Weimann§BayerHealthCare AG, Pharma Research Centre, WuppertalIrmingard GebertfBayer HealthCare, Bayer Vital GmbH, Pharma Medical Dept, LeverkusenHanno H. Leuchte**Dept of Internal Medicine I, Grosshadern Clinic, Ludwig Maximilian University of Munich, MunichJürgen Behr##Dept of Internal Medicine III, University Hospital Bergmannsheil, Bochum, Germany
- Everolimus improves exercise capacity and pulmonary vascular resistance in patients with advanced pulmonary hypertension – A pilot studyBy Hans-Juergen Seyfarth, Stefan Hammerschmidt, Michael Halank, Petra Neuhaus and Hubert WirtzHans-Juergen Seyfarth1Internal Medicine/Pneumology, University of Leipzig, Leipzig, GermanyStefan Hammerschmidt1Internal Medicine/Pneumology, University of Leipzig, Leipzig, GermanyMichael Halank2Internal Medicine/Pneumology, University of Dresden, Dresden, GermanyPetra Neuhaus1Internal Medicine/Pneumology, University of Leipzig, Leipzig, GermanyHubert Wirtz1Internal Medicine/Pneumology, University of Leipzig, Leipzig, Germany
- Prevalance and outcomes of pulmonary hypertension in chronic hypersensitivity pneumonitisBy Dirk Koschel, Carlos Cardoso, Bärbel Wiedemann, Gert Höffken and Michael HalankDirk Koschel1Department of Pulmonary Diseases, Fachkrankenhaus Coswig, Centre for Pulmonary Diseases and Thoracic Surgery, Coswig, GermanyCarlos Cardoso1Department of Pulmonary Diseases, Fachkrankenhaus Coswig, Centre for Pulmonary Diseases and Thoracic Surgery, Coswig, GermanyBärbel Wiedemann2Institute of Medical Informatics and Biometrics, Universitiy of Technology, Dresden, GermanyGert HöffkenMichael Halank3Department of Internal Medicine I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany
- Ambrisentan improves exercise capacity and symptoms in patients with portopulmonary hypertensionBy Michael Halank, Lars Knudsen, Hans-Juergen Seyfarth, Ralf Ewert, Baerbel Wiedemann, Martin Kolditz, Gert Hoeffken and Marius HoeperMichael Halank1Department of Internal Medicine I, University Hospital Carl Gustav Carus of TU Dresden, Dresden, GermanyLars Knudsen2Department of Respiratory Medicine, Hannover Medical School, Hannover, GermanyHans-Juergen Seyfarth3Department of Respiratory Medicine, University of Leipzig, Leipzig, GermanyRalf Ewert4Department of Cardiology and Respiratory Medicine, University Hospital Greifswald, Greifswald, GermanyBaerbel Wiedemann5Institute of Medical Informatics and Biometry, University of Dresden, Dresden, GermanyMartin Kolditz1Department of Internal Medicine I, University Hospital Carl Gustav Carus of TU Dresden, Dresden, GermanyGert Hoeffken1Department of Internal Medicine I, University Hospital Carl Gustav Carus of TU Dresden, Dresden, GermanyMarius Hoeper2Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany
- Efficacy of exercise training in congenital heart disease associated pulmonary hypertensionBy Tabea Becker-Gruenig, Nicola Ehlken, Matthias Gorenflo, Alfred Hager, Michael Halank, Hans Klose, Mona Lichtblau, Andreas Meyer, Frank Reichenberger, Stephan Sorichter, Rudolf Speich, Silvia Ulrich and Ekkehard GruenigTabea Becker-Gruenig1Centre for Pulmonary Hypertension, Thoraxclinic at the University of Heidelberg, GermanyNicola Ehlken1Centre for Pulmonary Hypertension, Thoraxclinic at the University of Heidelberg, GermanyMatthias Gorenflo2Department of Pediatric Cardiology and Congenital Heart Diseases, University Heidelberg, GermanyAlfred Hager3Department of Pediatric Cardiology and Congenital Heart Diseases, Deutsches Herzzentrum München des Freistaates Bayern, Technical University, Munich, GermanyMichael Halank4Department of Pneumology, Technical University, Dresden, GermanyHans Klose5Department of Pneumology, University Hamburg- Eppendorf, Hamburg, GermanyMona Lichtblau1Centre for Pulmonary Hypertension, Thoraxclinic at the University of Heidelberg, GermanyAndreas Meyer6Department of Pneumology, Clinics of Maria-Hilf, Mönchengladbach, GermanyFrank Reichenberger7Department of Pneumology, University of Giessen and Marburg, Giessen, GermanyStephan Sorichter8Department of Pneumology, University of Freiburg, GermanyRudolf Speich9Pulmonary Hypertension Program, University Hospital, Zurich, SwitzerlandSilvia Ulrich9Pulmonary Hypertension Program, University Hospital, Zurich, SwitzerlandEkkehard Gruenig1Centre for Pulmonary Hypertension, Thoraxclinic at the University of Heidelberg, Germany
- Copeptin predicts early clinical deterioration and persistent instability in community-acquired pneumoniaBy Martin Kolditz, Michael Halank, Bernhard Schulte-Hubbert, Sybille Bergmann, Steffen Albrecht and Gert HöffkenMartin Kolditz1Division of Pulmonology, Medical Department 1, University Hospital Carl Gustav Carus, Dresden, GermanyMichael Halank1Division of Pulmonology, Medical Department 1, University Hospital Carl Gustav Carus, Dresden, GermanyBernhard Schulte-Hubbert1Division of Pulmonology, Medical Department 1, University Hospital Carl Gustav Carus, Dresden, GermanySybille Bergmann2Institute of the Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Dresden, GermanySteffen Albrecht3Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus, Dresden, GermanyGert Höffken1Division of Pulmonology, Medical Department 1, University Hospital Carl Gustav Carus, Dresden, Germany
- Exercise training in pulmonary arterial hypertension associated with connective tissue diseasesBy Ekkehard Gruenig, Felicitas Maier, Nicola Ehlken, Christine Fischer, Mona Lichtblau, Norbert Blank, Christoph Fiehn, Frank Stöckl, Felix Prange, Gerd Staehler, Frank Reichenberger, Henning Thide, Michael Halank, Hans-Jürgen Seyfrath, Simone Wagner and Christian NagelEkkehard Gruenig1Center of Pulmonary Hypertension, Thoraxclinic Heidelberg, GermanyFelicitas Maier1Center of Pulmonary Hypertension, Thoraxclinic Heidelberg, GermanyNicola Ehlken1Center of Pulmonary Hypertension, Thoraxclinic Heidelberg, GermanyChristine Fischer2Departments of Human Genetics, University of Heidelberg, GermanyMona Lichtblau1Center of Pulmonary Hypertension, Thoraxclinic Heidelberg, GermanyNorbert Blank3Rheumatology and Neurology, University of Heidelberg, GermanyChristoph Fiehn4Rheumatology, ACURA Centre for Rheumatic Diseases, Baden-Baden, GermanyFrank Stöckl5Medical Clinic III, Clinic of Darmstadt, Darmstadt, GermanyFelix Prange1Center of Pulmonary Hypertension, Thoraxclinic Heidelberg, GermanyGerd Staehler6Medical Clinic I, Clinic of Loewenstein, GermanyFrank Reichenberger7Departments of Pneumology, Universities of Giessen, GermanyHenning Thide7Departments of Pneumology, Universities of Giessen, GermanyMichael Halank8Departments of Pneumology, Medical Clinic, Dresden, GermanyHans-Jürgen Seyfrath9Departments of Pneumology, University of Leipzig, GermanySimone Wagner3Rheumatology and Neurology, University of Heidelberg, GermanyChristian Nagel1Center of Pulmonary Hypertension, Thoraxclinic Heidelberg, Germany
- Effect of transnasal "high-flow oxygen insufflation" in patients with severe COPDBy Johannes Cleven, Helene Vogelsinger, Sebastian Ott, Thomas Geiser, Michael Halank and C.M. KählerJohannes Cleven1Department of General Internal Medicine I, Medical University of Innsbruck, Tyrol, AustriaHelene Vogelsinger1Department of General Internal Medicine I, Medical University of Innsbruck, Tyrol, AustriaSebastian Ott3Klinik und Poliklinik für Pneumologie, Universitätsspital, SwitzerlandThomas Geiser3Klinik und Poliklinik für Pneumologie, Universitätsspital, SwitzerlandMichael Halank2Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus, Dresden, GermanyC.M. Kähler1Department of General Internal Medicine I, Medical University of Innsbruck, Tyrol, Austria
- Exercise tests and anxiety independently reflect physical quality of life in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertensionBy Michael Halank, Franziska Einsle, Stephanie Christoph, Hinrich Bremer, Ralf Ewert, Heinrike Wilkens, Joachim Meyer, Hans-Juergen Seyfarth, Martin Kolditz, Gesine Wieder, Gert Hoeffken and Volker KoellnerMichael Halank1Internal Medicine I, University Hospital Carl Gustav Carus of TU Dresden, GermanyFranziska Einsle2Institute of Clinical Psychology and Psychotherapy, Technical University, Dresden, GermanyStephanie Christoph3Department of Nuclear Medicine, University Hospital Carl Gustav Carus of TU Dresden, GermanyHinrich Bremer4Internal Medicine, Schwarzwald-Baar Klinikum, Donaueschingen, GermanyRalf Ewert5Internal Medicine/Pulmonology, Ernst-Moritz-Arndt University, Greifswald, GermanyHeinrike Wilkens6Internal Medicine/Pulmonology, Saarland University Hospital, Homburg/Saar, GermanyJoachim Meyer7Internal Medicine/Pulmonology and Gastroenterology, Klinikum Harlaching, München, GermanyHans-Juergen Seyfarth8Pulmonary Medicine, University Hospital, Leipzig, GermanyMartin Kolditz1Internal Medicine I, University Hospital Carl Gustav Carus of TU Dresden, GermanyGesine Wieder2Institute of Clinical Psychology and Psychotherapy, Technical University, Dresden, GermanyGert Hoeffken1Internal Medicine I, University Hospital Carl Gustav Carus of TU Dresden, GermanyVolker Koellner9Institute of Psychosomatic Medicine, Saarland University Hospital, Homburg/Saar, Greenland
- Switch of patients with pulmonary arterial hypertension after withdrawal of the endothelin receptor antagonist sitaxentanBy David Pittrow, Ardeschir Ghofrani, Stephan Rosenkranz, Ekkehard Grünig, Dörte Huscher, Henning Tiede, Marion Delcroix, Gerd Stähler, Michael Halank, Matthias Held, Christian Grohé, Tobias J. Lange, Jürgen Behr, Hans Klose, Heinrike Wilkens, Rudolph Speich, Christian M. Kähler, Arthur Filusch, Martin Germann, Ralf Ewert, Hans-Jürgen Seyfarth, Karen M. Olsson, Christian F. Opitz, Sean P. Gaine, C. Dario Vizza, Anton Vonk-Noordegraaf, Harald Kaemmerer, J. Simon R. Gibbs, Oliver Distler, Christian Schweiger and Marius M. HoeperDavid Pittrow1Institute for Clinical Pharmacology, Technical University, Medical Faculty, Dresden, GermanyArdeschir Ghofrani2Department of Pneumology, Medical Clinic II, University of Giessen Lung Center, Giessen, GermanyStephan Rosenkranz3Clinic III for Internal Medicine (Cardiology), University Hospital, Cologne, GermanyEkkehard Grünig4Centre for Pulmonary Hypertension, Thoraxclinic, Heidelberg, GermanyDörte Huscher5Epidemiology Unit, German Rheumatism Research Centre, and Charité, Berlin, GermanyHenning Tiede2Department of Pneumology, Medical Clinic II, University of Giessen Lung Center, Giessen, GermanyMarion Delcroix7Dept. of Pneumology, University Hospitals, Leuven, BelgiumGerd Stähler8Medical Clinic I, Clinic Loewenstein, Loewenstein, GermanyMichael Halank9Internal Medicine I, University Hospital, Technical University, Dresden, GermanyMatthias Held10Dept. of Internal Medicine, Respiratory Medicine and Cardiology, Mission Medical Hospital, Würzburg, GermanyChristian Grohé11Dept. of Respiratory Medicine, ELK Thorax Center, Berlin, GermanyTobias J. Lange12Dept. of Internal Medicine II, Division of Pneumology, University Medical Center, Regensburg, GermanyJürgen Behr13Department of Internal Medicine V Comprehensive Pneumology Center Munich (CPC-M), University of Munich, Munich, GermanyHans Klose14Dept. of Respiratory Medicine, University Medical Center Hamburg-Eppendorf, Center of Oncology, Hamburg, GermanyHeinrike Wilkens15Dept. of Respiratory Medicine, University Hospital Saarland, Homburg, GermanyRudolph Speich16Clinic for Internal Medicine, University Hospital, Zurich, SwitzerlandChristian M. Kähler17Pneumology, University Hospital, Innsbruck, AustriaArthur Filusch18Dept. of Cardiology and Pneumology, University Hospital, Heidelberg, GermanyMartin Germann19Dept.of Pneumology, University Medical Centre, Freiburg, GermanyRalf Ewert20Clinic of Internal Medicine, Dept. of Respiratory Medicine, University of Greifswald, Greifswald, GermanyHans-Jürgen Seyfarth21Dept.of Respiratory Medicine, University Hospital, Leipzig, GermanyKaren M. Olsson6Dept of Respiratory Medicine and German Center of Lung Research, Hannover Medical School, Hannover, GermanyChristian F. Opitz22Dept. of Cardiology, DRK Kliniken Köpenick, Berlin, GermanySean P. Gaine23Dept. of Respiratory Medicine, Mater Misericordiae University Hospital, Dublin, IrelandC. Dario Vizza24Dept. of Cardiovascular and Respiratory Diseases, Sapienza University, Rome, ItalyAnton Vonk-Noordegraaf25Dept. of Pulmonary Diseases, VU University Medical Center, Amsterdam, NetherlandsHarald Kaemmerer26Dept. of Pediatric Cardiology and Congenital Cardiac Defects, German Heart Centre Munich, Munich, GermanyJ. Simon R. Gibbs27Dept. of Cardiology, National Heart & Lung Institute, Imperial College, London, United KingdomOliver Distler29Dept. of Rheumatology, University Hospital, Zurich, SwitzerlandChristian Schweiger28Inst. for Education in Pharmaceutical Medicine, University, Duisburg-Essen, GermanyMarius M. Hoeper6Dept of Respiratory Medicine and German Center of Lung Research, Hannover Medical School, Hannover, Germany
- Tobacco smoke in patients with pulmonary hypertensionBy Stephan Keusch, Florian Hildenbrand, Tom Bollmann, Michael Halank, Matthias Held, Ralf Kaiser, Gabor Kovacs, Tobias Lange, Rudolf Speich and Silvia Ulrich SomainiStephan Keusch1Clinic for Pulmonology, Department of Heart-Vessel-Thorax, University Hospital Zurich, Zurich, SwitzerlandFlorian Hildenbrand1Clinic for Pulmonology, Department of Heart-Vessel-Thorax, University Hospital Zurich, Zurich, SwitzerlandTom Bollmann1Clinic for Pulmonology, Department of Heart-Vessel-Thorax, University Hospital Zurich, Zurich, SwitzerlandMichael Halank1Clinic for Pulmonology, Department of Heart-Vessel-Thorax, University Hospital Zurich, Zurich, SwitzerlandMatthias Held1Clinic for Pulmonology, Department of Heart-Vessel-Thorax, University Hospital Zurich, Zurich, SwitzerlandRalf Kaiser1Clinic for Pulmonology, Department of Heart-Vessel-Thorax, University Hospital Zurich, Zurich, SwitzerlandGabor Kovacs1Clinic for Pulmonology, Department of Heart-Vessel-Thorax, University Hospital Zurich, Zurich, SwitzerlandTobias Lange1Clinic for Pulmonology, Department of Heart-Vessel-Thorax, University Hospital Zurich, Zurich, SwitzerlandRudolf Speich2Clinic for Internal Medicine, Department of Medicine-Oncology, University Hospital Zurich, Zurich, SwitzerlandSilvia Ulrich Somaini1Clinic for Pulmonology, Department of Heart-Vessel-Thorax, University Hospital Zurich, Zurich, Switzerland
- Randomized, controlled, prospective multicenter study: Training improves peak oxygen consumption and hemodynamics in patients with chronic severe pulmonary hypertensionBy Mona Lichtblau, Johannes Weidenhammer, Christian Nagel, Christine Fischer, Michael Halank, Hans Klose, Marius Hoeper, Werner Seeger, Horst Olschewski, Stefan Rosenkranz, Heinrike Wilkens, Tobias Lange, Dirk Mertens, Matthias Held, Martin Claussen, Christian Opitz, Ekkehard Grünig and Nicola EhlkenMona Lichtblau1Center for Pulmonary Hypertension, Thoraxclinic at the University of Heidelberg, Heidelberg, GermanyJohannes Weidenhammer1Center for Pulmonary Hypertension, Thoraxclinic at the University of Heidelberg, Heidelberg, GermanyChristian Nagel1Center for Pulmonary Hypertension, Thoraxclinic at the University of Heidelberg, Heidelberg, GermanyChristine Fischer2Institute of Human Genetics, University of Heidelberg, Heidelberg, GermanyMichael Halank3Pneumology, University Hospital of Dresden, Dresden, GermanyHans Klose4Pneumology, University Hospital Hamburg-Eppendorf, Hamburg, GermanyMarius Hoeper5Pneumology, Hannover Medical School, Hannover, GermanyWerner Seeger6Pneumology, University Hospital Gießen, Gießen, GermanyHorst Olschewski7Pneumology, University Hospital Graz, Graz, AustriaStefan Rosenkranz8Cardiology, University Hospital Cologne, Cologne, GermanyHeinrike Wilkens9Pneumology, University Hospital Homburg, Homburg, GermanyTobias Lange10Pneumology, University Hospital Regensburg, Regensburg, GermanyDirk Mertens11Cardiology, University Hospital Mainz, Mainz, GermanyMatthias Held12Pneumology, Medical Missionary Clinic Würzburg, Würzburg, GermanyMartin Claussen13Pneumology, Clinic Großhansdorf, Großhansdorf, GermanyChristian Opitz14Cardiology, DRK Clinics Berlin, Berlin, GermanyEkkehard Grünig1Center for Pulmonary Hypertension, Thoraxclinic at the University of Heidelberg, Heidelberg, GermanyNicola Ehlken1Center for Pulmonary Hypertension, Thoraxclinic at the University of Heidelberg, Heidelberg, Germany
- Riociguat for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Real-life data from the EXPERT registryBy Michael Halank, Marc Humbert, Miguel-Angel Gomez Sanchez, David Pittrow, Marius Hoeper, Ekkehard Grünig, H. Ardeschir Ghofrani, Hubert Wirtz, Hans Klose, Ralf Ewert, Tobias J. Lange, Jens Klotsche, Christian Meier, Monika Brunn and Gerald SimonneauMichael Halank1Medical Clinic I, Department of Pneumology, University Hospital Carl Gustav Carus, Dresden, GermanyMarc Humbert2Service de Pneumologie, Centre de Référence de l'Hypertension Pulmonaire Sévère, DHU Thorax Innovation, Hôpital Bicêtre, Université Paris-Sud, Le Kremlin-Bicêtre, FranceMiguel-Angel Gomez Sanchez3Unidad de Insuficiencia Cardiaca, Trasplante e Hipertensión Pulmonar, CIBERES, Hospital Universitario, Madrid, SpainDavid Pittrow4Institute for Clinical Pharmacology, Medical Faculty, Technical University, Carl Gustav Carus, Dresden, GermanyMarius Hoeper5Department of Respiratory Medicine and the German Center of Lung Research, Hanover Medical School, Hanover, GermanyEkkehard Grünig6Department of Respiratory Medicine, University of Leipzig, Leipzig, GermanyH. Ardeschir Ghofrani7Department of Internal Medicine, University Hospital Giessen and Marburg, Giessen, GermanyHubert Wirtz8Department of Respiratory Medicine, University of Leipzig, Leipzig, GermanyHans Klose9Section Pneumology, University Medical Centre Hamburg-Eppendorf, Hamburg, GermanyRalf Ewert10Department of Internal Medicine B - Cardiology, Intensive Care, Pulmonary Medicine and Infectious Diseases, Ernst-Moritz-Arndt University, Greifwald, GermanyTobias J. Lange11Department of Internal Medicine II, Division of Pneumology, University Medical Center, Regensburg, GermanyJens Klotsche12German Rheumatism Research Centre Berlin, Leibniz Institute, Berlin, GermanyChristian Meier13Bayer Pharma AG, Global Development, Global Medical Affairs, Berlin, GermanyMonika Brunn13Bayer Pharma AG, Global Development, Global Medical Affairs, Berlin, GermanyGerald Simonneau2Service de Pneumologie, Centre de Référence de l'Hypertension Pulmonaire Sévère, DHU Thorax Innovation, Hôpital Bicêtre, Université Paris-Sud, Le Kremlin-Bicêtre, France
- Riociguat for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH): Final data from a phase II long-term extension (LTE) studyBy Marius Hoeper, Hossein-Ardeschir Ghofrani, Michael Halank, F. Joachim Meyer, Gerd Stähler, Jürgen Behr, Ralf Ewert, Monique Fletcher, Pablo Colorado, Sylvia Nikkho, Janethe de Oliveira Pena and Friedrich GrimmingerMarius Hoeper1Clinic for Respiratory Medicine, Hannover Medical School, Member of the German Center of Lung Research (DZL), Hannover, GermanyHossein-Ardeschir Ghofrani2University of Giessen and Marburg Lung Center (UGMLC), Member of the German Center of Lung Research (DZL), Giessen, Germany3Deptment of Medicine, Imperial College London, London, United KingdomMichael Halank4Medical Clinic 1/Pneumology, University Hospital Carl Gustav Carus, Dresden, GermanyF. Joachim Meyer5Dept of Cardiology and Respiratory Medicine, University Hospital, Heidelberg, GermanyGerd Stähler6Medical Clinic 1, Loewenstein Clinic gGmbH, Loewenstein, GermanyJürgen Behr7Dept of Internal Medicine V, University of Munich and Asklepios Fachkliniken Munich-Gauting, Munich, GermanyRalf Ewert8Clinic for Internal Medicine B, Ernst-Moritz-Arndt-University Greifswald, Greifswald, GermanyMonique Fletcher9Global Clinical Development, Bayer plc, Newbury, United KingdomPablo Colorado10Global Clinical Development, Bayer Pharma AG, Barcelona, SpainSylvia Nikkho11Global Clinical Development, Bayer Pharma AG, Berlin, GermanyJanethe de Oliveira Pena12Global Clinical Development, Bayer Pharma AG, Whippany, United StatesFriedrich Grimminger2University of Giessen and Marburg Lung Center (UGMLC), Member of the German Center of Lung Research (DZL), Giessen, Germany
- Change of right heart size and function by long-term therapy with riociguat in patients with PAH and CTEPHBy Benjamin Egenlauf, Alberto Marra, Nicola Ehlken, Christine Fischer, Christina Eichstaedt, Christian Nagel, Eduardo Bossone, Antonio Cittadini, Michael Halank, Henning Gall, Karen Olsson, Tobias Lange and Ekkehard GrünigBenjamin Egenlauf1Centre for Pulmonary Hypertension, Thoraxclinic at the University of Heidelberg, Heidelberg, GermanyAlberto Marra1Centre for Pulmonary Hypertension, Thoraxclinic at the University of Heidelberg, Heidelberg, Germany22Internal Medicine Section-Department of Translational Medical Sciences, "Federico II" University School of Medicine, Naples, ItalyNicola Ehlken1Centre for Pulmonary Hypertension, Thoraxclinic at the University of Heidelberg, Heidelberg, GermanyChristine Fischer3Institute of Human Genetics, University of Heidelberg, Heidelberg, GermanyChristina Eichstaedt1Centre for Pulmonary Hypertension, Thoraxclinic at the University of Heidelberg, Heidelberg, GermanyChristian Nagel1Centre for Pulmonary Hypertension, Thoraxclinic at the University of Heidelberg, Heidelberg, Germany4Department of Pneumology, Clinic Mittelbaden, Baden-Baden, GermanyEduardo Bossone5Cardiology Division, "Cava de' Tirreni and Amalfi Coast" Hospital, University of Salerno, Salerno, Italy6Cardiac Surgery Dept., IRCCS Policlinico San Donato, Milan, ItalyAntonio Cittadini22Internal Medicine Section-Department of Translational Medical Sciences, "Federico II" University School of Medicine, Naples, ItalyMichael Halank7Medical Clinic I, University Hospital of TU Dresden, Dresden, GermanyHenning Gall8Department of Pneumology, University of Giessen Lung Center, Giessen, GermanyKaren Olsson9Department of Respiratory Medicine, Hannover Medical School, Hannover, GermanyTobias Lange10Internal Medicine II, University Medical Center Würzburg, Würzburg, GermanyEkkehard Grünig1Centre for Pulmonary Hypertension, Thoraxclinic at the University of Heidelberg, Heidelberg, Germany
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.